Cargando…
Interprovincial Differences in Access to Phosphate Lowering Medication; Implications for Care as Canada Moves Toward a National Pharmacare Program
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640798/ https://www.ncbi.nlm.nih.gov/pubmed/38020480 http://dx.doi.org/10.1177/20543581231207467 |
| _version_ | 1785133830502350848 |
|---|---|
| author | Wilson, Tristin E. Holden, Rachel M. |
| author_facet | Wilson, Tristin E. Holden, Rachel M. |
| author_sort | Wilson, Tristin E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10640798 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106407982023-11-10 Interprovincial Differences in Access to Phosphate Lowering Medication; Implications for Care as Canada Moves Toward a National Pharmacare Program Wilson, Tristin E. Holden, Rachel M. Can J Kidney Health Dis Opinion Piece SAGE Publications 2023-11-10 /pmc/articles/PMC10640798/ /pubmed/38020480 http://dx.doi.org/10.1177/20543581231207467 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Opinion Piece Wilson, Tristin E. Holden, Rachel M. Interprovincial Differences in Access to Phosphate Lowering Medication; Implications for Care as Canada Moves Toward a National Pharmacare Program |
| title | Interprovincial Differences in Access to Phosphate Lowering Medication; Implications for Care as Canada Moves Toward a National Pharmacare Program |
| title_full | Interprovincial Differences in Access to Phosphate Lowering Medication; Implications for Care as Canada Moves Toward a National Pharmacare Program |
| title_fullStr | Interprovincial Differences in Access to Phosphate Lowering Medication; Implications for Care as Canada Moves Toward a National Pharmacare Program |
| title_full_unstemmed | Interprovincial Differences in Access to Phosphate Lowering Medication; Implications for Care as Canada Moves Toward a National Pharmacare Program |
| title_short | Interprovincial Differences in Access to Phosphate Lowering Medication; Implications for Care as Canada Moves Toward a National Pharmacare Program |
| title_sort | interprovincial differences in access to phosphate lowering medication; implications for care as canada moves toward a national pharmacare program |
| topic | Opinion Piece |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640798/ https://www.ncbi.nlm.nih.gov/pubmed/38020480 http://dx.doi.org/10.1177/20543581231207467 |
| work_keys_str_mv | AT wilsontristine interprovincialdifferencesinaccesstophosphateloweringmedicationimplicationsforcareascanadamovestowardanationalpharmacareprogram AT holdenrachelm interprovincialdifferencesinaccesstophosphateloweringmedicationimplicationsforcareascanadamovestowardanationalpharmacareprogram |